13,14-dihydro-15-ketoprostaglandin e1 has been researched along with Dermatitis, Atopic in 1 studies
*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gieler, U; Happle, R; Krauss, M; Leonhardt, A; Schweer, H; Seyberth, HW | 1 |
1 other study(ies) available for 13,14-dihydro-15-ketoprostaglandin e1 and Dermatitis, Atopic
| Article | Year |
|---|---|
In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.
Topics: Adolescent; Adult; Alprostadil; Dermatitis, Atopic; Dinoprostone; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Skin | 1997 |